Perioperative Continuous Glucose Monitoring
To evaluate use of continuous glucose monitoring (CGM) technology in the preoperative setting: evaluate feasibility of placement of CGM during preoperative clinic visit with intent to utilize CGM throughout perioperative period.
Conditions:
🦠 Diabetes Mellitus
🗓️ Study Start (Actual) 4 August 2023
🗓️ Primary Completion (Estimated) January 2025
✅ Study Completion (Estimated) January 2025
👥 Enrollment (Estimated) 220
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Winston-Salem, North Carolina, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Participants that are 18 years of age or older with hyperglycemia and/or diabetes mellitus who will be undergoing surgery at Atrium Health Wake Forest Baptist
    • * smartphone compatible with Libre 2 phone application

    Exclusion Criteria:

    • * Pregnant women will not be excluded from this study
    • * Participants undergoing surgery that would limit the placement of Continuous Glucose Monitoring (CGM) to the posterior aspect of the upper extremity will be excluded from this study
    • * neurosurgical type of surgery
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 21 June 2023
  • First Submitted that Met QC Criteria 29 June 2023
  • First Posted 10 July 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 4 December 2023
  • Last Update Posted 11 December 2023
  • Last Verified December 2023